TheLion.com - Forum

Date: 06/26/2012 09:27

Forum: ADVENTRX Pharmaceuticals - Msg #2828

Thread #673419778 (Rec: 0)

ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug Product

http://finance.yahoo.com/news/adventrx-announces-manufacturing-agreement-patheon-120000892.html

SAN DIEGO, June 26, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that is has entered into a multi-year agreement with Patheon Inc. under which Patheon will formulate, fill and finish ANX-188 drug product for use in clinical trials, including the phase 3 study of ANX-188 that ADVENTRX plans to initiate this year.

"This agreement is another step toward initiating the phase 3 study of ANX-188 in patients with sickle cell disease," said Brian M. Culley, Chief Executive Officer of ADVENTRX. "Patheon is a global contract manufacturer that serves more than 300 customers, including many of the world's largest pharmaceutical and biotechnology companies. I am confident in their manufacturing expertise, experienced staff and world-class facilities and pleased to partner with them for the manufacture of ANX-188 clinical trial material

Share This Post:

NOTE: This message has been revised 1 time. Read original version of this message.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Optimist: Reward | Watch | IgnoreANX: Ignore